Aromasin and Herceptin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Aromasin (exemestane) and Herceptin (trastuzumab). Common drug interactions include fatigue among females and anxiety among males.
The phase IV clinical study analyzes what interactions people have when they take Aromasin and Herceptin. It is created by eHealthMe based on reports of 552 people who take the same drugs from the FDA, and is updated regularly.
What is Aromasin?
Aromasin has active ingredients of exemestane. It is often used in breast cancer. eHealthMe is studying from 12,863 Aromasin users. Check the latest studies of Aromasin.
What is Herceptin?
Herceptin has active ingredients of trastuzumab. It is often used in breast cancer. eHealthMe is studying from 42,205 Herceptin users. Check the latest studies of Herceptin.
552 people who take Aromasin and Herceptin together, and have interactions are studied.
What are the common drug interactions of Aromasin and Herceptin, by gender? *
What are the common drug interactions of Aromasin and Herceptin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Aromasin and Herceptin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Aromasin and Herceptin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Aromasin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Herceptin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aromasin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Herceptin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Saleh M, Bourcier T, Noel G, Speeg-Schatz C, Gaucher D, "Bilateral macular ischemia and severe visual loss following trastuzumab therapy", Acta Oncologica, 2011 Apr .
- Saleh M, Bourcier T, Noel G, Speeg-Schatz C, Gaucher D, "Bilateral macular ischemia and severe visual loss following trastuzumab therapy", Acta Oncologica, 2011 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on exemestane and trastuzumab (the active ingredients of Aromasin and Herceptin, respectively), and Aromasin and Herceptin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ankylosing Spondylitis and Vertigo Aggravated - 2 seconds ago
- Could Vitamin E cause Lymphopenia? - 4 seconds ago
- Jantoven vs. Amlodipine Besylate, side effect and effectiveness comparison - 7 seconds ago
- Could Omnitrope cause Dementia? - 13 seconds ago
- Could Spiriva cause Infected Sebaceous Cyst? - 15 seconds ago
- Could Adalat cause Taste - Impaired? - 16 seconds ago
- Could Cyclafem 7/7/7 cause Emotional Distress? - 16 seconds ago
- Could Aranesp cause Graft Dysfunction? - 18 seconds ago
- Analgesic Therapy and Drug Ineffective - 20 seconds ago
- Could Crestor cause Dizziness? - 27 seconds ago